Researcher profile

Adam Arany

Adam Arany contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 21 - EmergingVerification L1Unclaimed author
6works
0followers
2topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

6 published item(s)

preprint2026arXiv

A Comparative Study of QSPR Methods on a Unique Multitask PAMPA dataset

We present a unique, multitask dataset comprising 143 drug and drug candidate molecules, each evaluated on in vitro, parallel artificial-membrane permeability assays (PAMPA) using six different model membranes. Using this resource, we systematically assess the effectiveness of various molecular descriptors and regression models in predicting passive membrane permeability. The studied models range from simple linear regression to a modern pre-trained transformer architecture. Particular attention is given to the trade-off between predictive performance and model interpretability, highlighting the challenges introduced by machine learning approaches. To our knowledge, this is the most comprehensive study on simultaneous modeling of multiple organ-specific PAMPA membranes to date, offering novel insights into membrane-specific permeability profiles. We found that expert-designed physico-chemical property descriptors are more fitting for a limited sample size permeabilty study than deep learning based representations.

preprint2022arXiv

Collaborative Drug Discovery: Inference-level Data Protection Perspective

Pharmaceutical industry can better leverage its data assets to virtualize drug discovery through a collaborative machine learning platform. On the other hand, there are non-negligible risks stemming from the unintended leakage of participants' training data, hence, it is essential for such a platform to be secure and privacy-preserving. This paper describes a privacy risk assessment for collaborative modeling in the preclinical phase of drug discovery to accelerate the selection of promising drug candidates. After a short taxonomy of state-of-the-art inference attacks we adopt and customize several to the underlying scenario. Finally we describe and experiments with a handful of relevant privacy protection techniques to mitigate such attacks.

preprint2022arXiv

SparseChem: Fast and accurate machine learning model for small molecules

SparseChem provides fast and accurate machine learning models for biochemical applications. Especially, the package supports very high-dimensional sparse inputs, e.g., millions of features and millions of compounds. It is possible to train classification, regression and censored regression models, or combination of them from command line. Additionally, the library can be accessed directly from Python. Source code and documentation is freely available under MIT License on GitHub.

preprint2021arXiv

Self-Labeling of Fully Mediating Representations by Graph Alignment

To be able to predict a molecular graph structure ($W$) given a 2D image of a chemical compound ($U$) is a challenging problem in machine learning. We are interested to learn $f: U \rightarrow W$ where we have a fully mediating representation $V$ such that $f$ factors into $U \rightarrow V \rightarrow W$. However, observing V requires detailed and expensive labels. We propose graph aligning approach that generates rich or detailed labels given normal labels $W$. In this paper we investigate the scenario of domain adaptation from the source domain where we have access to the expensive labels $V$ to the target domain where only normal labels W are available. Focusing on the problem of predicting chemical compound graphs from 2D images the fully mediating layer is represented using the planar embedding of the chemical graph structure we are predicting. The use of a fully mediating layer implies some assumptions on the mechanism of the underlying process. However if the assumptions are correct it should allow the machine learning model to be more interpretable, generalize better and be more data efficient at training time. The empirical results show that, using only 4000 data points, we obtain up to 4x improvement of performance after domain adaptation to target domain compared to pretrained model only on the source domain. After domain adaptation, the model is even able to detect atom types that were never seen in the original source domain. Finally, on the Maybridge data set the proposed self-labeling approach reached higher performance than the current state of the art.

preprint2020arXiv

ChemGrapher: Optical Graph Recognition of Chemical Compounds by Deep Learning

In drug discovery, knowledge of the graph structure of chemical compounds is essential. Many thousands of scientific articles in chemistry and pharmaceutical sciences have investigated chemical compounds, but in cases the details of the structure of these chemical compounds is published only as an images. A tool to analyze these images automatically and convert them into a chemical graph structure would be useful for many applications, such drug discovery. A few such tools are available and they are mostly derived from optical character recognition. However, our evaluation of the performance of those tools reveals that they make often mistakes in detecting the correct bond multiplicity and stereochemical information. In addition, errors sometimes even lead to missing atoms in the resulting graph. In our work, we address these issues by developing a compound recognition method based on machine learning. More specifically, we develop a deep neural network model for optical compound recognition. The deep learning solution presented here consists of a segmentation model, followed by three classification models that predict atom locations, bonds and charges. Furthermore, this model not only predicts the graph structure of the molecule but also produces all information necessary to relate each component of the resulting graph to the source image. This solution is scalable and could rapidly process thousands of images. Finally, we compare empirically the proposed method to a well-established tool and observe significant error reductions.

preprint2020arXiv

Expressive Graph Informer Networks

Applying machine learning to molecules is challenging because of their natural representation as graphs rather than vectors.Several architectures have been recently proposed for deep learning from molecular graphs, but they suffer from informationbottlenecks because they only pass information from a graph node to its direct neighbors. Here, we introduce a more expressiveroute-based multi-attention mechanism that incorporates features from routes between node pairs. We call the resulting methodGraph Informer. A single network layer can therefore attend to nodes several steps away. We show empirically that the proposedmethod compares favorably against existing approaches in two prediction tasks: (1) 13C Nuclear Magnetic Resonance (NMR)spectra, improving the state-of-the-art with an MAE of 1.35 ppm and (2) predicting drug bioactivity and toxicity. Additionally, wedevelop a variant called injective Graph Informer that isprovablyas powerful as the Weisfeiler-Lehman test for graph isomorphism.Furthermore, we demonstrate that the route information allows the method to be informed about thenonlocal topologyof the graphand, thus, even go beyond the capabilities of the Weisfeiler-Lehman test.